Suchergebnisse - "1381-6128" OR "1873-4286"

PubPharm (199)

191

COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy

enthalten in: Current pharmaceutical design | 2020

von Rahman, M. | Akter, R. | Behl, T. | +5

192

The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases

enthalten in: Current pharmaceutical design | 2020

von Martinez, G. | Zabaleta, M. | Di Giulio, C. | +2

193

Pentoxifylline and Oxypurinol : Potential Drugs to Prevent the "Cytokine Release (Storm) Syndrome" Caused by SARS-CoV-2?

enthalten in: Current pharmaceutical design | 2020

von López-Iranzo, F. | López-Rodas, A. | Franco, L. | +1

194

Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds : A Multilayered High Throughput Virtual Screening Approach

enthalten in: Current pharmaceutical design | 2020

von Dhasmana, A. | Kashyap, V. | Dhasmana, S. | +6

CommentIn: Curr Pharm Des. 2020;26(41):5221-5223. - PMID 33327907

195

Targeting Natural Products for the Treatment of COVID-19 - An Updated Review

enthalten in: Current pharmaceutical design | 2020

von Pamuru, R. | Ponneri, N. | Damu, A. | +1

196

The Emergence of Human Pathogenic Coronaviruses : Lectins as Antivirals for SARS-CoV-2

enthalten in: Current pharmaceutical design | 2020

von Sohrab, S. | Suhail, M. | Kamal, M. | +2

197

Design and Delivery of Therapeutic siRNAs : Application to MERS-Coronavirus

enthalten in: Current pharmaceutical design | 2018

von Sohrab, S. | El-Kafrawy, S. | Mirza, Z. | +2

198

Drug design targeting the main protease, the Achilles' heel of coronaviruses

enthalten in: Current pharmaceutical design | 2006

von Yang, H. | Bartlam, M. | Rao, Z.

199

Editorial [Hot Topic: SARS-CoV: A Scenario of Modern Drug Design (Executive Editor: X. Huang)]

enthalten in: Current pharmaceutical design | 2006

von Huang, X.

[1]
« Vorheriger
10
11
12
13
14
15
16
17
18
19
20